Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | FABP3 | P05413 | 1/20 | 0.45 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | AKT1 | P31749 | 2/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | PRKCG | P05129 | 1/20 | 0.33 |
| ▸ | PRKCB | P05771 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | PRKCH | P24723 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157824 | 1.00 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| SCHEMBL5019714 | 1.00 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| SCHEMBL8899300 | 1.00 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| SCHEMBL27168721 | 1.00 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| Glycerin SCHEMBL28844001 | 0.98 | SMN1; SMN2 (0.68) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| Glycerin SCHEMBL28844000 | 0.98 | SMN1; SMN2 (0.68) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| Choline SCHEMBL29922745 | 0.95 | SMN1; SMN2 (0.64) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| SCHEMBL14950221 | 0.90 | SMN1; SMN2 (0.57) | SMN1; SMN2FABP3SELPLMNAAKT1 | |
| SCHEMBL18471995 | 0.89 | SMN1; SMN2 (0.56) | SMN1; SMN2FABP3LMNAAKT1ADRA1A | |
| SCHEMBL13212932 | 0.87 | SMN1; SMN2 (0.53) | SMN1; SMN2FABP3LMNAAKT1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646401-A1 | NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY | CELON PHARMA S.A. (PL) | 2025-11-12 | — | — | EP | claimed |
| EP-3830829-B1 | SYSTEMS AND METHODS FOR METABOLOME ANALYSIS | 10X GENOMICS INC (US) | 2024-10-02 | — | — | EP | claimed |
| WO-2024147060-A1 | NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY | CELON PHARMA S.A. (PL) | 2024-07-11 | — | — | WO | claimed |
| US-11873530-B1 | Systems and methods for metabolome analysis | 10X GENOMICS, INC. (US) | 2024-01-16 | — | — | US | claimed |
| US-11617757-B2 | Dietary supplement | MORRISETTE JAMES PETER (US) | 2023-04-04 | — | — | US | claimed |
| US-11596640-B2 | Dietary supplement | MORRISSETTE JAMES PETER (US) | 2023-03-07 | — | — | US | claimed |
| US-11590143-B2 | Dietary supplement | MORRISSETTE JAMES PETER (US) | 2023-02-28 | — | — | US | claimed |
| EP-4061423-A1 | HYPERACTIVE DENDRITIC CELLS ENABLE DURABLE ADOPTIVE CELL TRANSFER-BASED ANTI-TUMOR IMMUNITY | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-09-28 | — | — | EP | claimed |
| EP-4061409-A1 | STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-09-28 | — | — | EP | claimed |
| US-20220211720-A1 | DIETARY SUPPLEMENT | MORRISSETTE JAMES PETER (US) | 2022-07-07 | — | — | US | claimed |
| CN-102421431-A | Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds | CREARENE LTD | 2012-04-18 | — | — | CN | claimed |
| CN-102213698-A | Detection method of related substances of glycerophosphorylcholine injection | KELUN PHARMACEUTICAL | 2011-10-12 | — | — | CN | claimed |
| CN-1700909-B | Treatment solution and application for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells | ZHANG JIN JUN | 2011-05-18 | — | — | CN | claimed |
| CN-1956780-B | Affinity particles and affinity separation method | SHISEIDO CO LTD | 2011-03-23 | — | — | CN | claimed |
| CN-101862295-A | Aggregate having enhanced deformability and including at least three amphipatic substances | IDEA AG | 2010-10-20 | — | — | CN | claimed |
| EP-1918371-A1 | NOVEL PHOSPHOLIPID PROCESSING AGENT | Asahi Kasei Pharma Corporation (JP) | 2008-05-07 | — | — | EP | claimed |
| CN-1703199-A | Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin | IDEA AG (DE) | 2005-11-30 | — | — | CN | claimed |
| CN-1700909-A | Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells | ZHANG JIN JUN (CN) | 2005-11-23 | — | — | CN | claimed |
| CN-1676125-A | Nano-level emulsion containing taxine or hard-soluble medicine | ZHANG HAO (CN) | 2005-10-05 | — | — | CN | claimed |
| CN-1311665-A | Novel analgesic, anti-inflammatory and wound healing agent | EPIGENESIS PHARMACEUTICALS INC (US) | 2001-09-05 | — | — | CN | claimed |